Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Original Research

Global Prevalence and Major Risk Factors of Diabetic Retinopathy

  1. Joanne W.Y. Yau, MBBS1,
  2. Sophie L. Rogers, MEPID1,
  3. Ryo Kawasaki, PHD1,
  4. Ecosse L. Lamoureux, PHD1,2,
  5. Jonathan W. Kowalski, PHARMD3,
  6. Toke Bek, PHD4,
  7. Shih-Jen Chen, PHD5,
  8. Jacqueline M. Dekker, PHD6,
  9. Astrid Fletcher, PHD7,
  10. Jakob Grauslund, MD8,
  11. Steven Haffner, PHD9,
  12. Richard F. Hamman, PHD10,
  13. M. Kamran Ikram, PHD11,
  14. Takamasa Kayama, MD12,
  15. Barbara E.K. Klein, PHD13,
  16. Ronald Klein, PHD13,
  17. Sannapaneni Krishnaiah, MD14,
  18. Korapat Mayurasakorn, MD15,
  19. Joseph P. O’Hare, MD16,
  20. Trevor J. Orchard, MD17,
  21. Massimo Porta, PHD18,
  22. Mohan Rema, MD19,
  23. Monique S. Roy, MD20,
  24. Tarun Sharma, MD21,
  25. Jonathan Shaw, PHD22,
  26. Hugh Taylor, AC23,
  27. James M. Tielsch, PHD24,
  28. Rohit Varma, MD25,
  29. Jie Jin Wang, PHD26,
  30. Ningli Wang, MD27,
  31. Sheila West, PHD28,
  32. Liang Xu, PHD29,
  33. Miho Yasuda, PHD30,
  34. Xinzhi Zhang, PHD31,
  35. Paul Mitchell, PHD26,
  36. Tien Y. Wong, PHD1,2,32⇓ and
  37. for the Meta-Analysis for Eye Disease (META-EYE) Study Group*
  1. 1Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia
  2. 2Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore
  3. 3Global Health Outcomes Strategy and Research, Allergan Inc., Irvine, California
  4. 4Department of Ophthalmology, Aarhus University Hospital, Aarhus, Denmark
  5. 5Department of Ophthalmology, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan
  6. 6Department of Epidemiology and Biostatistics and the EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, the Netherlands
  7. 7Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, U.K.
  8. 8Department of Ophthalmology, Odense University Hospital, Odense, Denmark
  9. 9Shavano Park, Texas
  10. 10Department of Epidemiology, Colorado School of Public Health, Aurora, Colorado
  11. 11Departments of Epidemiology and Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands
  12. 12National Cancer Center/Department of Neurosurgery, Advanced Molecular Epidemiology Research Institute, Faculty of Medicine, Yamagata University, Yamagata, Japan
  13. 13Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin
  14. 14Center for Clinical Epidemiology and Biostatistics, L V Prasad Eye Institute, Hyderabad, India
  15. 15Department of Social Medicine, Samutsakhon General Hospital, Samutsakhon, Thailand
  16. 16Clinical Sciences Research Institute, Warwick Medical School, University of Warwick, Coventry, U.K.
  17. 17Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
  18. 18Department of Internal Medicine, University of Turin, Turin, Italy
  19. 19Department of Ophthalmology, Madras Diabetes Research Foundation, Chennai, India
  20. 20Institute of Ophthalmology and Visual Science, University of New Jersey, Newark, New Jersey
  21. 21Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, India
  22. 22Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
  23. 23Melbourne School of Population Health, University of Melbourne, Melbourne, Victoria, Australia
  24. 24Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
  25. 25Doheny Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, California
  26. 26Centre for Vision Research, Westmead Millennium Institute, University of Sydney, Sydney, New South Wales, Australia
  27. 27Beijing Tongren Hospital, Capital Medical University, Beijing, China
  28. 28Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore, Maryland
  29. 29Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China
  30. 30Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
  31. 31Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
  32. 32Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
  1. Corresponding author: Tien Y. Wong, ophwty{at}nus.edu.sg.
Diabetes Care 2012 Mar; 35(3): 556-564. https://doi.org/10.2337/dc11-1909
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Abstract

OBJECTIVE To examine the global prevalence and major risk factors for diabetic retinopathy (DR) and vision-threatening diabetic retinopathy (VTDR) among people with diabetes.

RESEARCH DESIGN AND METHODS A pooled analysis using individual participant data from population-based studies around the world was performed. A systematic literature review was conducted to identify all population-based studies in general populations or individuals with diabetes who had ascertained DR from retinal photographs. Studies provided data for DR end points, including any DR, proliferative DR, diabetic macular edema, and VTDR, and also major systemic risk factors. Pooled prevalence estimates were directly age-standardized to the 2010 World Diabetes Population aged 20–79 years.

RESULTS A total of 35 studies (1980–2008) provided data from 22,896 individuals with diabetes. The overall prevalence was 34.6% (95% CI 34.5–34.8) for any DR, 6.96% (6.87–7.04) for proliferative DR, 6.81% (6.74–6.89) for diabetic macular edema, and 10.2% (10.1–10.3) for VTDR. All DR prevalence end points increased with diabetes duration, hemoglobin A1c, and blood pressure levels and were higher in people with type 1 compared with type 2 diabetes.

CONCLUSIONS There are approximately 93 million people with DR, 17 million with proliferative DR, 21 million with diabetic macular edema, and 28 million with VTDR worldwide. Longer diabetes duration and poorer glycemic and blood pressure control are strongly associated with DR. These data highlight the substantial worldwide public health burden of DR and the importance of modifiable risk factors in its occurrence. This study is limited by data pooled from studies at different time points, with different methodologies and population characteristics.

Footnotes

  • This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc11-1909/-/DC1.

  • ↵* A complete list of the study group can be found in the Supplementary Data online.

  • The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Eye Institute or the National Institutes of Health. The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

  • Received October 25, 2011.
  • Accepted December 5, 2011.
  • © 2012 by the American Diabetes Association.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

View Full Text
Back to top
Diabetes Care: 44 (3)

Current Issue

March 2021
Volume 44, Issue 3

  • Current Issue
  • Index by Author
  • Issue Archive
  • Podcasts
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Global Prevalence and Major Risk Factors of Diabetic Retinopathy
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Global Prevalence and Major Risk Factors of Diabetic Retinopathy
Joanne W.Y. Yau, Sophie L. Rogers, Ryo Kawasaki, Ecosse L. Lamoureux, Jonathan W. Kowalski, Toke Bek, Shih-Jen Chen, Jacqueline M. Dekker, Astrid Fletcher, Jakob Grauslund, Steven Haffner, Richard F. Hamman, M. Kamran Ikram, Takamasa Kayama, Barbara E.K. Klein, Ronald Klein, Sannapaneni Krishnaiah, Korapat Mayurasakorn, Joseph P. O’Hare, Trevor J. Orchard, Massimo Porta, Mohan Rema, Monique S. Roy, Tarun Sharma, Jonathan Shaw, Hugh Taylor, James M. Tielsch, Rohit Varma, Jie Jin Wang, Ningli Wang, Sheila West, Liang Xu, Miho Yasuda, Xinzhi Zhang, Paul Mitchell, Tien Y. Wong, for the Meta-Analysis for Eye Disease (META-EYE) Study Group
Diabetes Care Mar 2012, 35 (3) 556-564; DOI: 10.2337/dc11-1909

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Global Prevalence and Major Risk Factors of Diabetic Retinopathy
Joanne W.Y. Yau, Sophie L. Rogers, Ryo Kawasaki, Ecosse L. Lamoureux, Jonathan W. Kowalski, Toke Bek, Shih-Jen Chen, Jacqueline M. Dekker, Astrid Fletcher, Jakob Grauslund, Steven Haffner, Richard F. Hamman, M. Kamran Ikram, Takamasa Kayama, Barbara E.K. Klein, Ronald Klein, Sannapaneni Krishnaiah, Korapat Mayurasakorn, Joseph P. O’Hare, Trevor J. Orchard, Massimo Porta, Mohan Rema, Monique S. Roy, Tarun Sharma, Jonathan Shaw, Hugh Taylor, James M. Tielsch, Rohit Varma, Jie Jin Wang, Ningli Wang, Sheila West, Liang Xu, Miho Yasuda, Xinzhi Zhang, Paul Mitchell, Tien Y. Wong, for the Meta-Analysis for Eye Disease (META-EYE) Study Group
Diabetes Care Mar 2012, 35 (3) 556-564; DOI: 10.2337/dc11-1909
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Original Research

  • n-3 Fatty Acid Biomarkers and Incident Type 2 Diabetes: An Individual Participant-Level Pooling Project of 20 Prospective Cohort Studies
  • Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study
  • Glycemic Outcome Associated With Insulin Pump and Glucose Sensor Use in Children and Adolescents With Type 1 Diabetes. Data From the International Pediatric Registry SWEET
Show more Original Research

Epidemiology/Health Services Research

  • Risk of Blindness Among Patients With Diabetes and Newly Diagnosed Diabetic Retinopathy
  • Prediabetes, Diabetes, and the Risk of All-Cause and Cause-Specific Mortality in a Japanese Working Population: Japan Epidemiology Collaboration on Occupational Health Study
  • Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes
Show more Epidemiology/Health Services Research

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.